Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4G6F

Crystal Structure of 10E8 Fab in Complex with an HIV-1 gp41 Peptide

Summary for 4G6F
Entry DOI10.2210/pdb4g6f/pdb
Descriptor10E8 Heavy Chain, 10E8 Light Chain, gp41 MPER Peptide, ... (4 entities in total)
Functional Keywordsimmunoglobulin, mper, antibody, immune system
Biological sourceHomo sapiens (human)
More
Total number of polymer chains6
Total formula weight106130.40
Authors
Ofek, G.,Huang, J.,Connors, M.,Kwong, P.D. (deposition date: 2012-07-19, release date: 2012-09-26, Last modification date: 2024-10-30)
Primary citationHuang, J.,Ofek, G.,Laub, L.,Louder, M.K.,Doria-Rose, N.A.,Longo, N.S.,Imamichi, H.,Bailer, R.T.,Chakrabarti, B.,Sharma, S.K.,Alam, S.M.,Wang, T.,Yang, Y.,Zhang, B.,Migueles, S.A.,Wyatt, R.,Haynes, B.F.,Kwong, P.D.,Mascola, J.R.,Connors, M.
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody.
Nature, 491:406-412, 2012
Cited by
PubMed Abstract: Characterization of human monoclonal antibodies is providing considerable insight into mechanisms of broad HIV-1 neutralization. Here we report an HIV-1 gp41 membrane-proximal external region (MPER)-specific antibody, named 10E8, which neutralizes ∼98% of tested viruses. An analysis of sera from 78 healthy HIV-1-infected donors demonstrated that 27% contained MPER-specific antibodies and 8% contained 10E8-like specificities. In contrast to other neutralizing MPER antibodies, 10E8 did not bind phospholipids, was not autoreactive, and bound cell-surface envelope. The structure of 10E8 in complex with the complete MPER revealed a site of vulnerability comprising a narrow stretch of highly conserved gp41-hydrophobic residues and a critical arginine or lysine just before the transmembrane region. Analysis of resistant HIV-1 variants confirmed the importance of these residues for neutralization. The highly conserved MPER is a target of potent, non-self-reactive neutralizing antibodies, suggesting that HIV-1 vaccines should aim to induce antibodies to this region of HIV-1 envelope glycoprotein.
PubMed: 23151583
DOI: 10.1038/nature11544
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.1 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon